Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1995-3-30
|
pubmed:abstractText |
The expression of drug resistance-associated mdr-1, GST pi, and topoisomerase II genes was analyzed in cell cycle phase enriched populations of doxorubicin-resistant murine leukemic P388/R-84 cells. Flow cytometric analysis of bromodeoxyuridine (BrdU) incorporation and staining with anti-BrdU antibodies was used to confirm the purity of cell cycle phase enriched populations obtained by centrifugal elutriation. Doxorubicin (DOX) and daunorubicin (DNR) accumulation was significantly lower in S-phase cells, and coincubation with verapamil (VPL) or chlorpromazine (CPZ) enhanced DOX and DNR accumulation more in S-phase than in G1- and G2/M-phase cells. While the cellular content of mdr-1 and topoisomerase II mRNAs changed, GST pi mRNA content remained constant during the cell cycle. S-phase cells had about 3-fold higher mdr-1 mRNA content than G1- and G2/M-phase cells. In G1 cells, P-glycoprotein expression, as determined by C219 monoclonal antibody, was 12% less than that of S and G2/M cells. Topoisomerase II mRNA content increased with the progression of cell cycle and peaked in G2/M cells. These observations suggest that cell cycle stage related changes in expression of drug resistance markers may have a major bearing on chemosensitivity of drug-resistant cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA Topoisomerases, Type II,
http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Transferase,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0006-2952
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
545-52
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7872960-Animals,
pubmed-meshheading:7872960-Cell Cycle,
pubmed-meshheading:7872960-Cell Line,
pubmed-meshheading:7872960-Cricetinae,
pubmed-meshheading:7872960-Cricetulus,
pubmed-meshheading:7872960-DNA Topoisomerases, Type II,
pubmed-meshheading:7872960-Daunorubicin,
pubmed-meshheading:7872960-Doxorubicin,
pubmed-meshheading:7872960-Drug Resistance, Multiple,
pubmed-meshheading:7872960-Glutathione Transferase,
pubmed-meshheading:7872960-Interphase,
pubmed-meshheading:7872960-Mice,
pubmed-meshheading:7872960-P-Glycoprotein,
pubmed-meshheading:7872960-RNA, Messenger
|
pubmed:year |
1995
|
pubmed:articleTitle |
Expression of drug resistance-associated mdr-1, GST pi, and topoisomerase II genes during cell cycle traverse.
|
pubmed:affiliation |
Michigan Cancer Foundation, Detroit 48201.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|